These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22970199)

  • 1. Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation.
    Platania CB; Salomone S; Leggio GM; Drago F; Bucolo C
    PLoS One; 2012; 7(9):e44316. PubMed ID: 22970199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of key receptor-ligand interactions of dopaminergic arylpiperazines and the dopamine D2 receptor homology model.
    Sukalovic V; Soskic V; Sencanski M; Andric D; Kostic-Rajacic S
    J Mol Model; 2013 Apr; 19(4):1751-62. PubMed ID: 23300056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism.
    Lane JR; Abramyan AM; Adhikari P; Keen AC; Lee KH; Sanchez J; Verma RK; Lim HD; Yano H; Javitch JA; Shi L
    Elife; 2020 Jan; 9():. PubMed ID: 31985399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling and docking study on dopamine D2-like and serotonin 5-HT2A receptors.
    Duan X; Zhang M; Zhang X; Wang F; Lei M
    J Mol Graph Model; 2015 Apr; 57():143-55. PubMed ID: 25728902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of molecular dynamics sampling on the performance of virtual screening against GPCRs.
    Tarcsay A; Paragi G; Vass M; Jójárt B; Bogár F; Keserű GM
    J Chem Inf Model; 2013 Nov; 53(11):2990-9. PubMed ID: 24116387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity and activation of dopamine D3R from molecular dynamics.
    Feng Z; Hou T; Li Y
    J Mol Model; 2012 Dec; 18(12):5051-63. PubMed ID: 22752545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the structural basis and atomistic binding mechanistic of the selective antagonist blockade at D
    Appiah-Kubi P; Olotu FA; Soliman MES
    J Mol Recognit; 2021 May; 34(5):e2885. PubMed ID: 33401335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for Na(+)-sensitivity in dopamine D2 and D3 receptors.
    Michino M; Free RB; Doyle TB; Sibley DR; Shi L
    Chem Commun (Camb); 2015 May; 51(41):8618-21. PubMed ID: 25896577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical analysis of the successes and failures of homology models of G protein-coupled receptors.
    Bhattacharya S; Lam AR; Li H; Balaraman G; Niesen MJ; Vaidehi N
    Proteins; 2013 May; 81(5):729-39. PubMed ID: 23042299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology modeling of the human 5-HT1A, 5-HT 2A, D1, and D2 receptors: model refinement with molecular dynamics simulations and docking evaluation.
    Yap BK; Buckle MJ; Doughty SW
    J Mol Model; 2012 Aug; 18(8):3639-55. PubMed ID: 22354276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine D2 and D3 receptors.
    Michino M; Donthamsetti P; Beuming T; Banala A; Duan L; Roux T; Han Y; Trinquet E; Newman AH; Javitch JA; Shi L
    Mol Pharmacol; 2013 Dec; 84(6):854-64. PubMed ID: 24061855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-optimized homology models of D₁ and D₂ dopamine receptors: application for virtual screening.
    Kołaczkowski M; Bucki A; Feder M; Pawłowski M
    J Chem Inf Model; 2013 Mar; 53(3):638-48. PubMed ID: 23398329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtype selectivity of dopamine receptor ligands: insights from structure and ligand-based methods.
    Wang Q; Mach RH; Luedtke RR; Reichert DE
    J Chem Inf Model; 2010 Nov; 50(11):1970-85. PubMed ID: 20936866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
    Chen H; Fu W; Wang Z; Wang X; Lei T; Zhu F; Li D; Chang S; Xu L; Hou T
    ACS Chem Neurosci; 2019 Jan; 10(1):677-689. PubMed ID: 30265513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dopamine D2 receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics.
    Kaczor AA; Jörg M; Capuano B
    J Mol Model; 2016 Sep; 22(9):203. PubMed ID: 27491852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-target dopamine D3 receptor modulators: Actionable knowledge for drug design from molecular dynamics and machine learning.
    Ferraro M; Decherchi S; De Simone A; Recanatini M; Cavalli A; Bottegoni G
    Eur J Med Chem; 2020 Feb; 188():111975. PubMed ID: 31940507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.
    Varady J; Wu X; Fang X; Min J; Hu Z; Levant B; Wang S
    J Med Chem; 2003 Oct; 46(21):4377-92. PubMed ID: 14521403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs.
    Ferruz N; Doerr S; Vanase-Frawley MA; Zou Y; Chen X; Marr ES; Nelson RT; Kormos BL; Wager TT; Hou X; Villalobos A; Sciabola S; De Fabritiis G
    Sci Rep; 2018 Jan; 8(1):897. PubMed ID: 29343833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analogues of Arylamide Phenylpiperazine Ligands To Investigate the Factors Influencing D3 Dopamine Receptor Bitropic Binding and Receptor Subtype Selectivity.
    Hayatshahi HS; Xu K; Griffin SA; Taylor M; Mach RH; Liu J; Luedtke RR
    ACS Chem Neurosci; 2018 Dec; 9(12):2972-2983. PubMed ID: 30010318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the structural prediction of G protein-coupled receptors: D3 receptor in complex with eticlopride.
    Obiol-Pardo C; López L; Pastor M; Selent J
    Proteins; 2011 Jun; 79(6):1695-703. PubMed ID: 21491496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.